Further, the lower efficacy was not associated with pretreatment tumor size, implying that outgrowth of a specific subpopulation, under the selection of IFN-α treatment, may produce alternative pro-angiogenesis factors or activate an alternative pathway. Here, IFNA1 is linked to neoplasm.